AC
ALINA CHAKRABORTY
Barts Cancer Institute, Institut Curie, University of Calcutta
0000-0002-9223-8635
About
I am a researcher investigating the role of post-transcriptional regulation such as splicing, poly-adenylation, RNA localisation, mRNA stability and translation on cancer progression and therapy resistance over 15 years. Currently I am a senior post-doctoral fellow at Barts Cancer Institute in London.
Employment
-
Barts Cancer Institute Post-doctoral Researcher2022 - Present
-
Institut Curie Post-doctoral Researcher2016 - 2022
-
University of Calcutta Research Fellow2009 - 2015
Education
-
University of Calcutta M Sc2006 - 2008
-
University of Calcutta B Sc.2003 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Interplay of microRNA-20a and HuR in the regulation of beclin1 during Withaferin-A mediated impaired autophagy in Breast Cancer cell-line, MCF-7 Save
- Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin. Save
- Differential Effects on the Translation of Immune-Related Alternatively Polyadenylated mRNAs in Melanoma and T Cells by eIF4A Inhibition Save
- ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion. Save
- ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin. Save
- Abstract LB-323: A novel function of ETS transcription factors in alternative splicing is altered in oncogenic FET-ETS fusions Save
- Phorbol-12-myristate-13-acetate-mediated stabilization of leukemia inhibitory factor (lif) mRNA: involvement of Nucleolin and PCBP1. Save
- Stabilization of Oncostatin-M mRNA by Binding of Nucleolin to a GC-Rich Element in Its 3'UTR. Save
- Regulation of Gene Expression through mRNA Stability: Implications in Cancer Development and Therapeutics Save